Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Industry stakeholders have worked to enhance patient centricity in research and development in recent years in hopes of improving patient engagement and ensuring they have a stronger voice in their clinical care.
This noticeable shift toward patient centricity also intends to help sponsors address long-standing challenges in successfully designing and executing clinical trials. Decentralized trial solutions are being validated in terms of accommodating patients' needs to improve their trial experiences while also benefiting sponsors in reducing trial delays and related costs while not compromising patient safety or data quality.
Sabrina Steffen
Head of Data Strategy and Innovation for DSSM
Greg Temesi
Senior Director, Connected Devices
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Ensure you have access to insights early with connected devices and clean, analysis-ready data